Bladder Adenocarcinoma, also known as adenocarcinoma of bladder, is related to bladder signet ring cell adenocarcinoma and bladder clear cell adenocarcinoma, and has symptoms including dysuria An important gene associated with Bladder Adenocarcinoma is UCA1 (Urothelial Cancer Associated 1), and among its related pathways/superpathways are Adhesion and Pancreatic cancer subtypes. The drugs Pembrolizumab and Ipilimumab have been mentioned in the context of this disorder. Affiliated tissues include prostate and lymph node.